Dan Kastner wins Crafoord Prize in PolyarthritisFebruary 3, 2021PediatricsImmunologyRheumatologyRare DiseasesMusculoskeletal Disorders
Data call for biologics trials in undertreated juvenile arthritis subtypeJanuary 7, 2021PediatricsMusculoskeletal DisordersRare DiseasesRheumatology
FDA clears first drug for rare genetic causes of severe obesityDecember 4, 2020ObesityRare DiseasesPreventive Care
A 4-year-old presented to our pediatric dermatology clinic for evaluation of asymptomatic "brown spots."November 10, 2020PediatricsDermatologyRare Diseases
Higher cardiovascular risks in Kawasaki disease persist 10-plus yearsNovember 8, 2020PediatricsRare DiseasesCardiologyRheumatology
Birch bark derivative gel found effective for EB, in phase 3 studyNovember 3, 2020Rare DiseasesPediatricsDermatology
Systemic sclerosis patients share their perspectives and needs in treatment trialsOctober 21, 2020DermatologyRheumatologyRare Diseases
Golimumab approval extended to polyarticular-course JIA and juvenile PsAOctober 2, 2020PediatricsRheumatologyRare DiseasesMusculoskeletal Disorders
FDA adds polyarticular-course JIA to approved indications for tofacitinibSeptember 30, 2020PediatricsRare DiseasesMusculoskeletal DisordersRheumatology
COVID-19 linked to development of myasthenia gravisAugust 21, 2020COVID-19 UpdatesRare DiseasesNeurology
Terlipressin squeaks by FDA review for hepatorenal syndrome 1July 17, 2020GastroenterologyNephrologyRare Diseases
First reported U.S. case of COVID-19 linked to Guillain-Barré syndromeJune 24, 2020COVID-19 UpdatesRare DiseasesNeurology
